TITLE

HIV Antiretroviral Drug Resistance

AUTHOR(S)
Campo, Jose E.; Jamjian, Christine; Goulston, Claudia
PUB. DATE
July 2012
SOURCE
Journal of AIDS & Clinical Research;Special2012, Vol. 3 Issue S, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article describes some of the challenges in the use of highly active antiretroviral therapy (HAART) from the perspective of HIV resistance. It defines drug resistance in HIV as a reduced susceptibility to a specific antiretroviral (ARV) and has been documented since the introduction of ARV therapy. The types and mechanism of resistance are described. Also noted are the characteristics that facilitate the development of resistance.
ACCESSION #
86429366

 

Related Articles

  • The Safety of Interruption of HAART in Patients Who Never Met the Current Criteria for HIV Treatment Initiation. Deresinski, Stan // Clinical Infectious Diseases;9/15/2006, Vol. 43 Issue 6, pvi 

    The article discusses the research "Safe Treatment interruptions in patients with nadir CD4 counts of more than 350 cells/μL: a randomized trial," published in the 2006 issue of the "Journal of Acquired Immune Deficiency Syndrome" which evaluates the safety of the discontinuation of highly...

  • Importance of Dose Timing to Achieving Undetectable Viral Loads. Gill, Christopher J.; Sabin, Lora L.; Hamer, Davidson H.; Xu Keyi; Zhang Jianbo; Tao Li; Wan-Ju Wu; Wilson, Ira B.; DeSilva, Mary Bachman // AIDS & Behavior;Aug2010, Vol. 14 Issue 4, p785 

    Little is known about the importance of dose timing to successful antiretroviral therapy (ART). In a cohort comprised of Chinese HIV/AIDS patients, we measured adherence among subjects for 6 months using three methods in parallel: self-report using a visual analog scale (SR-VAS), pill count, and...

  • Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive Women. Cook, Judith A.; Cohen, Mardge H.; Grey, Dennis; Kirstein, Lynn; Burke, Jane; Anastos, Kathryn; Palacio, Herminia; Richardson, Jean; Wilson, Tracey E.; Young, Mary // American Journal of Public Health;Jan2002, Vol. 92 Issue 1, p82 

    Objectives. This study examined longitudinal trends in use of highly active antiretroviral therapy (HAART) among a cohort of HIV-positive participants in the Women's Interagency HIV Study. Methods. Beginning in 1994, 1690 HIV-positive women reported detailed information about their use of...

  • Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study. Dahab, Mison; Charalambous, Salome; Karstaedt, Alan S.; Fielding, Katherine L.; Hamilton, Robin; La Grange, Lettie; Churchyard, Gavin J.; Grant, Alison D. // BMC Public Health;2010, Vol. 10 Issue 1, p430 

    Background: Many national antiretroviral therapy (ART) programmes encourage providers to identify and address baseline factors associated with poor treatment outcomes, including modifiable adherence-related behaviours, before initiating ART. However, evidence on such predictors is scarce, and...

  • Emerging Trends of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving First-Line Highly Active Antiretroviral Therapy: A Systematic Review and Meta-Analysis. Liu, Huixin; Ma, Ye; Su, Yingying; Smith, M. Kumi; Liu, Ying; Jin, Yantao; Gu, Hongqiu; Wu, Jing; Zhu, Lin; Wang, Ning // Clinical Infectious Diseases;Nov2014, Vol. 59 Issue 10, p1495 

    Our study finds a rising trend of human immunodeficiency virus (HIV) drug resistance prevalence over longer durations of highly active antiretroviral therapy. China might face the danger of a new HIV epidemic generated by transmitted drug resistance.Background. Highly active antiretroviral...

  • Morphological and Metabolic Components of Lipodystrophy in Various Nevirapine-Based Highly Active Antiretroviral Therapy (HAART) Regimens. Guaraldi, Giovanni; Zona, Stefano; Orlando, Gabriella; Carli, Federica; Stentarelli, Chiara; Luzi, Kety; Garlassi, Elisa; Menozzi, Marianna; Bagni, Pietro; Adorni, Fulvio // Clinical Drug Investigation;2011, Vol. 31 Issue 11, p759 

    Background: Morphological abnormalities (lipoatrophy and central fat accumulation) and metabolic changes (dyslipidaemia and glucose regulation impairment) have emerged as components of lipodystrophy and as major tolerability issues with long-term use of highly active antiretroviral therapy...

  • Screening for and Verification of Novel Mutations Associated with Drug Resistance in the HIV Type 1subtype B' in China. Hanping Li; Qingmao Geng; Wei Guo; Daomin Zhuang; Lin Li; Yongjian Liu; Zuoyi Bao; Siyang Liu; Jingyun Li // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Objective: Mutations associated with HIV drug resistance have been extensively characterized at the HIV-1 polymerase domain, but more studies have verified that mutations outside of the polymerase domain also results in resistance to antiviral drugs. In this study, mutations were identified in...

  • Transmitted Antiretroviral Drug Resistance in New York State, 2006-2008: Results from a New Surveillance System. Readhead, Adam C.; Gordon, Daniel E.; Wang, Zhengyan; Anderson, Bridget J.; Brousseau, Kathleen S.; Kouznetsova, Maria A.; Forgione, Lisa A.; Smith, Lou C.; Torian, Lucia V.; Chêne, Geneviève // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Background: HIV transmitted drug resistance (TDR) is a public health concern because it has the potential to compromise antiretroviral therapy (ART) at the population level. In New York State, high prevalence of TDR in a local cohort and a multiclass resistant case cluster led to the...

  • Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea. Gare, Janet; Ryan, Claire E.; David, Matthew; Timbi, Diana; Kaima, Petronia; Kombati, Zure; Imara, Ulato; Kelly-Hanku, Angela; Siba, Peter M.; Crowe, Suzanne M.; Hearps, Anna C. // Journal of Antimicrobial Chemotherapy (JAC);Aug2014, Vol. 69 Issue 8, p2183 

    Objectives The optimal benefits of antiretroviral therapy (ART) can be compromised by the emergence of HIV drug resistance (HIVDR) resulting in treatment failure. ART was introduced in Papua New Guinea (PNG) in 2004, yet biological data on HIVDR are lacking. The aim of the study was to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics